DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Dittmann RW, Cardo E, Nagy P et al.
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
CNS Drugs 2013;
27: 1081-1092
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.